Skip to main content
. 2022 Aug 30;45(11):2683–2688. doi: 10.2337/dc22-0708

Table 1.

Characteristics of study participants: total and stratified by inpatient glycemic values

Variable Total (n = 1,938) Normoglycemia (glucose ≤180 mg/dL) (n = 622) Hyperglycemia (glucose ≥180 mg/dL) (n = 1,316) P for trend
Demographic characteristics
 Age (years) 68.08 ± 13.7 67.27 ± 14.71 68.46 ± 13.18 0.09
 Sex
  Male 963 (49.69) 291 (46.78) 672 (51.06)
  Female 975 (50.31) 331 (53.22) 644 (48.94) 0.08
 Race
  White 195 (18.77) 76 (21.47) 119 (17.37)
  Black 789 (75.94) 266 (75.14) 523 (76.35)
  Other 55 (5.29) 12 (3.39) 43 (6.28) 0.06
 Ethnicity
  Hispanic 691 (39.64) 207 (36.77) 484 (41.02)
  Not Hispanic 1,052 (60.36) 356 (63.23) 696 (58.98) 0.09
 Insurance
  Medicaid 827 (42.78) 260 (41.80) 260 (41.80)
  Medicare 915 (47.34) 290 (46.62) 625 (47.67)
  Commercial 191 (9.88) 72 (11.58) 119 (9.08) 0.23
Clinical characteristics and laboratory parameters
 BMI (kg/m2) 29.92 ± 7.25 30.48 ± 0.3 29.65 ± 0.2 0.02
 HbA1c (%) 7.26 ± 1.95 6.05 ± 0.76 7.85 ± 2.07 <0.001
 CRP (mg/L) 10.9 (4.9–19.2) 7.6 (3.7–14.7) 12.7 (5.8–21) <0.001
 D-dimer (μg/mL) 1.74 (0.89–3.34) 1.31 (0.7–2.5) 1.74 (1.01–3.62) <0.001
Comorbidities
 Hypertension
  No 318 (16.41) 122 (19.61) 196 (14.89)
  Yes 1,620 (83.59) 500 (80.39) 1,120 (85.11) 0.009
 Previous stroke
  No 1,355 (79.19) 429 (80.94) 926 (78.41)
  Yes 356 (20.81) 101 (19.06) 255 (21.59) 0.23
 Coronary artery disease
  No 1,206 (62.23) 416 (66.88) 790 (60.03)
  Yes 732 (37.77) 206 (33.12) 526 (39.97) 0.004
 Peripheral artery disease
  No 1,757 (90.66) 594 (95.50) 1,163 (88.37)
  Yes 181 (9.34) 28 (4.50) 153 (11.63) <0.001
 Chronic kidney disease
  No 1,305 (67.34) 452 (72.67) 853 (64.82)
  Yes 633 (32.66) 170 (27.33) 463 (35.18) <0.001
 Chronic obstructive pulmonary disease
  No 1,493 (87.26) 451 (85.09) 1,042 (88.23)
  Yes 218 (12.74) 79 (14.91) 139 (11.77) 0.07

Data are mean ± SD, n (%) or median (IQR). Laboratory results were obtained on admission to the hospital.